Description Absenz Oral Solution (100 mL) is a liquid formulation of Ethosuximide 250 mg per 5 mL, manufactured by Sun Pharmaceutical Industries Ltd. It is primarily used in the management of absence seizures (petit mal) and myoclonic seizures, conditions characterized by brief lapses in consciousness and involuntary muscle jerks, respectively. Ethosuximide functions by inhibiting excessive electrical activity in the brain, thereby reducing the frequency and severity of these seizures.​ Key Features: Active Ingredient: Ethosuximide 250 mg per 5 mL Formulation: Oral solution Indications: Absence seizures, myoclonic seizures Manufacturer: Sun Pharmaceutical Industries Ltd Dosage Form: 100 mL bottle​ Usage Instructions: Dosage: Administer as prescribed by a healthcare professional. Administration: Take orally, with or without food. Storage: Store below 30°C in a cool, dry place.​ Precautions: Regular monitoring of blood counts and liver function may be required during treatment. Avoid abrupt discontinuation; tapering under medical supervision is recommended. Consult a healthcare provider before use in pregnant or breastfeeding individuals.​ Side Effects: Common side effects may include nausea, vomiting, abdominal pain, dizziness, and drowsiness. If any adverse reactions persist or worsen, seek medical attention promptly.​